Nifedipine Tablet, Extended Release
Product Images NDC 68382-688

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 68382-688). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (56f20159 9fff 4ab0 Bac9 F1362dc843a4 01)

Chemical structure of NIFEDIPINE, showing the detailed molecular arrangement including nitro group, ester groups, and the dihydropyridine ring characteristic of this calcium channel blocker.*

FDA Label Image

Container Label 30 mg (56f20159 9fff 4ab0 Bac9 F1362dc843a4 02)

NIFEdipine Extended-Release Tablets 30 mg in a 100-tablet package by Zydus Pharmaceuticals USA Inc. The label includes a tablet image marked with '585' and storage instructions. Manufactured by Cadila Healthcare Ltd., India, with a National Drug Code 68382-688-01. The label advises swallowing tablets whole and keeping drugs out of children's reach.*

FDA Label Image

Carton Label 30 mg (56f20159 9fff 4ab0 Bac9 F1362dc843a4 03)

Carton packaging label for NIFEdipine Extended-Release Tablets, 30 mg dosage strength. The label shows the medication name, dosage form as extended-release tablets, oral route, and strength prominently. It includes storage instructions, a note that the unit-dose package is not child-resistant, and the labeler as Zydus Pharmaceuticals USA Inc. The package contains 100 unit-dose tablets with the manufacturer listed as Cadila Healthcare Ltd., India. The NDC number 68382-688-77 is displayed along with a barcode.*

FDA Label Image

Container Label 60 mg (56f20159 9fff 4ab0 Bac9 F1362dc843a4 04)

NIFEDIPINE Extended-Release Tablets, 60 mg strength, oral dosage form, package contains 100 tablets. Label shows a round beige tablet with imprint '689'. Manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc. Storage instructions and safety warnings are included on the label.*

FDA Label Image

Carton Label 60 mg (56f20159 9fff 4ab0 Bac9 F1362dc843a4 05)

Packaging label for NIFEdipine Extended-Release Tablets 60 mg. The label features the product name prominently, dosage strength, and instructions that tablets should be swallowed whole. It includes a small image of a yellow round tablet imprinted with '689,' and indicates the package contains 100 unit-dose tablets. The labeler is Zydus Pharmaceuticals (USA) Inc., with manufacturing information for Cadila Healthcare Ltd., India. Storage and handling instructions, lot-specific NDC number 68382-689-77, a barcode, and standard warnings are also displayed.*

FDA Label Image

Container Label 90 mg (56f20159 9fff 4ab0 Bac9 F1362dc843a4 06)

Label for NIFEdipine Extended-Release Tablets 90 mg by Zydus Pharmaceuticals USA Inc. The label shows a tan round tablet imprinted with '90'. It states the strength (90 mg), extended-release form, 100 tablets per container, and directions that tablets should be swallowed whole. Storage and safety warnings are included, with manufacturing by Cadila Healthcare Ltd. in India and distribution by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Carton Label 90 mg (56f20159 9fff 4ab0 Bac9 F1362dc843a4 07)

NIFEdipine 90 mg extended-release oral tablets packaging label from Zydus Pharmaceuticals USA Inc. The label shows the drug name, dosage strength, and a tablet image imprinted with '690'. The label indicates unit-dose packaging of 100 tablets (10 x 10), storage instructions, and warnings about swallowing tablets whole. Manufacturer is Cadila Healthcare Ltd., India. The label includes the NDC number 68382-690-77 and bar code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.